TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Swedish Biomedical Consulting AB
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
32
|
259
|
160 |
| Financial expenses |
0
|
49
|
0 |
| Earnings before taxes |
301
|
108
|
76 |
| EBITDA |
-49
|
156
|
76 |
| Total assets |
716
|
436
|
340 |
| Current assets |
716
|
436
|
340 |
| Current liabilities |
328
|
233
|
239 |
| Equity capital |
388
|
203
|
101 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
54.2%
|
46.6%
|
29.7% |
| Turnover per employee |
32
|
259
|
160 |
| Profit as a percentage of turnover |
940.6%
|
41.7%
|
47.5% |
| Return on assets (ROA) |
42.0%
|
36.0%
|
22.4% |
| Current ratio |
218.3%
|
187.1%
|
142.3% |
| Return on equity (ROE) |
77.6%
|
53.2%
|
75.2% |
| Change turnover |
-227
|
99
|
160 |
| Change turnover % |
-88%
|
62% | |
| Chg. No. of employees |
0
|
0
|
1 |
| Chg. No. of employees % |
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.